PDFs by language
Our 24/7 cancer helpline provides support for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. We connect patients, caregivers, and family members with valuable services and resources.
Or ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
While there are a few known risk factors for neuroblastoma, the cause of most neuroblastomas is not known. Still, researchers have found important differences between neuroblastoma cells and the normal neuroblasts (early forms of nerve cells) from which they develop.
Nerve cells and cells in the medulla (center) of the adrenal gland start out as neuroblasts in a growing fetus. Most often, neuroblasts grow and develop into mature cells. Neuroblastomas can occur when normal fetal neuroblasts do not become mature cells, but instead continue to grow and divide.
Some neuroblasts might not have matured completely by the time a baby is born. Most of these eventually mature into normal nerve cells over time, or they simply die off and do not form neuroblastomas.
But sometimes, neuroblasts remaining in very young infants continue to grow and form a tumor. Many of these tumors will still eventually mature into nerve tissue or go away on their own. But as children get older, it becomes less likely that these cells will mature, and more likely that they will grow into a cancer.
The reason some neuroblasts don't mature is because they have changes in the DNA inside the cells. DNA is the chemical in each of our cells that makes up our genes, which control how our cells function. The DNA in our cells is in long, string-like structures called chromosomes.
Some genes normally control when our cells grow, divide into new cells, and die:
Cancers can be caused by DNA changes that create oncogenes, or that turn off tumor suppressor genes. These gene changes can sometimes be inherited from a parent (which is rare with neuroblastomas), or they may happen during a person's lifetime as cells in the body divide to make new cells.
Most often, neuroblastoma cells have chromosome changes (such as having too many or too few chromosomes, or missing part of a chromosome) that are likely to affect certain genes. Scientists are still trying to determine which genes are affected by these chromosome changes, as well as how these changes affect the growth of neuroblastoma cells.
Most neuroblastomas are the result of gene changes in neuroblasts that happen during the child’s development, sometimes even before birth. What causes these acquired gene changes is not known. They might be just be random events that sometimes happen inside cells, without having an outside cause.
These acquired gene changes are found only in the child’s cancer cells, so they will not be passed on to their children.
In rare cases, neuroblastoma occurs as a result of gene changes inherited from a parent. Inherited changes in certain genes account for most hereditary (familial) neuroblastomas:
Some other gene changes seem to affect how quickly a neuroblastoma can grow:
It's still not clear what causes many of the gene and chromosome changes that can lead to neuroblastoma. There are no known lifestyle-related or environmental causes of neuroblastomas, so it's important to remember that there is nothing these children or their parents could have done to prevent these cancers.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Dome JS, Rodriguez-Galindo C, Spunt SL, Santana VM. Chapter 92: Pediatric solid tumors. In: Neiderhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, PA. Elsevier; 2020.
Pinto NR, Applebaum MA, Volchenboum SL, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015: 30;3008-3017.
Park JR, Hogarty MD, Bagatell R, et al. Chapter 23: Neuroblastoma. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Principles and Practice of Pediatric Oncology. 8th ed. Philadelphia Pa: Lippincott Williams & Wilkins; 2021.
Shohet JM, Nuchtern JG. Epidemiology, pathogenesis, and pathology of neuroblastoma. UpToDate. 2021. Accessed at https://www.uptodate.com/contents/epidemiology-pathogenesis-and-pathology-of-neuroblastoma on March 4, 2021.
Last Revised: April 28, 2021
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.